VEGFA and neoplasm: The vascular endothelial growth factor, such as bevacizumab, is an important regulator of tumor angiogenesis and metastasis.[14,15] Bevacizumab plays various roles in the tumor blood vessels by specifically binding to vascular endothelial growth factor and blocking its interaction with receptors.[16]